Chinese Academy of Sciences;Shanghai Institute of Materia Medica
发明人:
申请号：
EP16813720.6
公开号：
EP3315502A1
申请日:
2016.06.23
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides C, O-spiro aryl glycoside compounds, preparation therefor and use thereof. Specifically provided are the compounds represented by the formula (I), wherein the definitions of each group are described in the specification. The compound can be used as SGLT2 inhibitors in preparing the pharmaceutical compositions for treating diseases such as diabetes, atherosclerosis, adiposity and etc.
